Abstract
We report the case of a 79-year-old woman with hepatocellular carcinoma (HCC) who presented with creatine kinase (CK)-MM elevation. On admission, her serum CK-MM level exceeded 4000 IU/L (normal, 44–206 IU/L), and computed tomography revealed two HCCs in hepatic segment VIII (23 mm, 86 mm). The patient denied experiencing muscular symptoms such as weakness or pain. Hypothyroidism, ischemic heart disease, muscular dystrophy, autoimmune myopathy, drug-induced rhabdomyolysis, and paraneoplastic inflammatory myositis syndrome (PIMS) were included in the differential diagnosis for high CK-MM, but none were suspected. Although the cause of elevated CK-MM was not elucidated, an HCC-related mechanism was considered and the tumor was resected. The CK-MM levels declined gradually to 300 IU/L postoperatively without any special perioperative management. Nineteen cases of HCC-associated CK-MM elevation have been reported in English thus far, in all of which, inflammatory myositis was concluded as the cause of CK-MM elevation. However, in this case, the elevation of CK-MM was associated with HCC-related mechanisms distinct from PIMS, suggesting HCC-related mechanisms should not be excluded as a cause of high CK-MM, even though PIMS is negative.
Similar content being viewed by others
References
Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–213.
Kazak L, Cohen P. Creatine metabolism: energy homeostasis, immunity and cancer biology. Nat Rev Endocrinol. 2020;16:421–36.
Bárdos D, Molnár MJ, Dudás I, et al. Polymyositis and rhabdomyolysis caused by hepatocellular carcinoma—case report and literature review. Ann Med Surg (Lond). 2021;65:102269.
Sattar MA, Guindi RT, Khan RA, et al. Polymyositis and hepatocellular carcinoma. Clin Rheumatol. 1988;7:538–42.
Horie Y, Yamada M, Nakai K, et al. Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis. J Gastroenterol Hepatol. 1989;4:101–4.
Hasegawa K, Uesugi H, Kubota K, et al. Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma. Hepatogastroenterology. 2000;47:1425–7.
Inuzuka M, Tomita K, Tokura Y, et al. Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma. Br J Dermatol. 2001;144:416–7.
Cheng TI, Tsou MH, Yang PS, et al. Dermatomyositis and erythrocytosis associated with hepatocellular carcinoma. J Gastroenterol Hepatol. 2002;17:1239–40.
Kim MJ, Kim JA, Sung MS, et al. Hepatocellular carcinoma, polymyositis, rhabdomyolysis, and acute renal failure. J Korean Med Sci. 2004;19:891–4.
Kee KM, Wang JH, Lee CM, et al. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma. Chang Gung Med J. 2004;27:834–9.
Toshikuni N, Torigoe R, Mitsunaga M, et al. Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis. World J Gastroenterol. 2006;12:1641–4.
Kee SJ, Kim TJ, Lee SJ, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Rheumatol Int. 2009;29:595–9.
Apostolidis L, Kahlert C, Siegmund A, et al. Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib. Onkologie. 2009;32:50–3.
Kishore D, Khurana V, Raj A, et al. Hepatocellular carcinoma presenting as polymyositis: a paraneoplastic syndrome. Ann Saudi Med. 2011;31:533–5.
Tekaya R, Abdelghni K, Abdelmoula L, et al. Hepatocellular carcinoma with polymyositis as an initial symptom: a case report. Acta Clin Belg. 2011;66:53–4.
Yang SY, Cha BK, Kim G, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Korean J Intern Med. 2014;29:231–5.
Thanapirom K, Aniwan S, Treeprasertsuk S. Polymyositis associated with hepatitis B virus cirrhosis and advanced hepatocellular carcinoma. ACG Case Rep J. 2014;1:167–9.
Miyata N, Emoto K, Dei Y, et al. Paraneoplastic dermatomyositis in hepatocellular carcinoma with colonic perforation: a case report. Case Rep Oncol. 2016;9:547–53.
Chou JW, Lin YL, Cheng KS, et al. Dermatomyositis induced by hepatitis B virus-related hepatocellular carcinoma: a case report and review of the literature. Intern Med. 2017;56:1831–7.
Han J, Wang S, Kwong TNY, et al. Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: a case report and literature review. Med (Baltim). 2018;97:e11586.
Meng-Ko T, Yi-Hsin C, You-Hsin C, et al. Hepatocellular carcinoma-associated polymyositis presenting with unilateral upper limb subcutaneous edema. Arch Rheumatol. 2018;33:482–7.
Bottai M, Tjärnlund A, Santoni G, et al. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017;3:e000507.
Carney DN, Zweig MH, Ihde DC, et al. Elevated serum creatine kinase BB levels in patients with small cell lung cancer. Cancer Res. 1984;44:5399–403.
Zarghami N, Giai M, Yu H, et al. Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients. Br J Cancer. 1996;73:386–90.
Meffert G, Gellerich FN, Margreiter R, et al. Elevated creatine kinase activity in primary hepatocellular carcinoma. BMC Gastroenterol. 2005;5:9.
Kanemitsu F, Kawanishi I, Mizushima J, et al. Mitochondrial creatine kinase as a tumor-associated marker. Clin Chim Acta. 1984;138:175–83.
Soroida Y, Ohkawa R, Nakagawa H, et al. Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence. J Hepatol. 2012;57:330–6.
Vaubourdolle M, Chazouilleres O, Poupon R, et al. Creatine kinase-BB: a marker of liver sinusoidal damage in ischemia-reperfusion. Hepatology. 1993;17:423–8.
Acknowledgements
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interest.
Ethical approval
This article satisfied the consensus of the National Center for Global Health and Medicine Research Ethics Committee/Institutional Review Board.
Informed consent
Written informed consent was obtained from the patient described in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nakamura, Y., Ito, K., Takemura, N. et al. Elevation in creatine kinase isoenzyme-MM associated with hepatocellular carcinoma: a case report and review of literature. Clin J Gastroenterol 15, 460–466 (2022). https://doi.org/10.1007/s12328-022-01612-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-022-01612-w